Essential Partners’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$131 Hold
1
– – ﹤0.01% 2666
2026
Q2
$189 Hold
1
– – ﹤0.01% 2649
2026
Q1
$93 Hold
1
– – ﹤0.01% 2726
2025
Q4
$80 Hold
1
– – ﹤0.01% 2580
2025
Q3
$98 Buy
+1
New +$81 ﹤0.01% 2495

Other funds holding ACLS

Essential Partners's ACLS Position: Q3 2026 in Review

Essential Partners held its Axcelis (ACLS) position steady in Q3 2026 at 1 share worth $131. The position accounts for ﹤0.01% of the portfolio, ranked #2666.

Essential Partners first reported a position in ACLS in Q3 2025 and has held it in 5 quarters since. The position peaked at $189 in Q2 2026. 21 funds tracked by Wall St. Rank hold ACLS as of Q3 2026.

  • Essential Partners held 1 share of Axcelis worth $131 as of Q3 2026.
  • Essential Partners left its Axcelis share count unchanged in Q3 2026.
  • Axcelis made up ﹤0.01% of Essential Partners's portfolio in Q3 2026, its #2666 holding.
  • Essential Partners first reported a position in Axcelis in Q3 2025 and has held it in 5 quarters since.
  • Essential Partners's Axcelis position peaked at $189 in Q2 2026.
  • 21 funds tracked by Wall St. Rank held Axcelis as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.